Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology

Free Medical Books

  Dermatology

  Free Subscription


Articles published in Int J Cancer

Retrieve available abstracts of 71 articles:
HTML format
Text format



Single Articles


    January 2012
  1. RUGBJERG K , Friis S, Lassen CF, Ritz B, et al
    Malignant melanoma, breast cancer and other cancers in patients with parkinson disease.
    Int J Cancer. 2012 Jan 25. doi: 10.1002/ijc.27443.
    PubMed     Text format     Related articles    Abstract available



  2. VAN BREEST SMALLENBURG V , Duijm LE, Voogd AC, Groenewoud JH, et al
    Lower sensitivity of screening mammography after previous benign breast surgery.
    Int J Cancer. 2012;130:122-8.
    PubMed     Text format     Related articles    Abstract available



  3. JACQUEMIER J , Bertucci F, Finetti P, Esterni B, et al
    High expression of indoleamine 2,3-dioxygenase in the tumour is associated with medullary features and favourable outcome in basal-like breast carcinoma.
    Int J Cancer. 2012;130:96-104.
    PubMed     Text format     Related articles    Abstract available



    December 2011
  4. MADDAMS J , Parkin DM, Darby SC
    The cancer burden in the United Kingdom in 2007 due to radiotherapy.
    Int J Cancer. 2011;129:2885-93.
    PubMed     Text format     Related articles    Abstract available



    November 2011
  5. HEMMINKI K , Liu X, Ji J, Sundquist J, et al
    Kaposi sarcoma and merkel cell carcinoma after autoimmune disease.
    Int J Cancer. 2011 Nov 28. doi: 10.1002/ijc.27376.
    PubMed     Text format     Related articles   



  6. CUST AE , Goumas C, Holland EA, Agha-Hamilton C, et al
    MC1R genotypes and risk of melanoma before age 40 years: A population-based case-control-family study.
    Int J Cancer. 2011 Nov 18. doi: 10.1002/ijc.27357.
    PubMed     Text format     Related articles    Abstract available



  7. SANGER N , Effenberger KE, Riethdorf S, Van Haasteren V, et al
    Disseminated tumor cells in the bone marrow of patients with ductal carcinoma in situ.
    Int J Cancer. 2011;129:2522-6.
    PubMed     Text format     Related articles    Abstract available



  8. LAMBERT SR , Harwood CA, Purdie KJ, Gulati A, et al
    Metastatic cutaneous squamous cell carcinoma show frequent deletion in the protein tyrosine phosphatase receptor type D gene.
    Int J Cancer. 2011 Nov 2. doi: 10.1002/ijc.27333.
    PubMed     Text format     Related articles    Abstract available



    October 2011
  9. IZRAELY S , Sagi-Assif O, Klein A, Meshel T, et al
    The metastatic microenvironment. brain residing melanoma metastasis and dormant micro-metastasis.
    Int J Cancer. 2011 Oct 25. doi: 10.1002/ijc.27324.
    PubMed     Text format     Related articles    Abstract available



  10. SCHAEFER C , Butterfield LH, Lee S, Kim GG, et al
    Function but not phenotype of melanoma peptide-specific CD8(+) T cells correlate with survival in a multi-epitope peptide vaccine trial (ECOG 1696).
    Int J Cancer. 2011 Oct 24. doi: 10.1002/ijc.26481.
    PubMed     Text format     Related articles    Abstract available



  11. CHATTOPADHYAY C , Ellerhorst JA, Ekmekcioglu S, Greene VR, et al
    Association of activated c-Met with NRAS-mutated human melanomas: A possible avenue for targeting.
    Int J Cancer. 2011 Oct 24. doi: 10.1002/ijc.26487.
    PubMed     Text format     Related articles    Abstract available



  12. BENDER C , Ullrich A
    PRKX, TTBK2 and RSK4 expression causes sunitinib resistance in kidney carcinoma- and melanoma cell lines.
    Int J Cancer. 2011 Oct 23. doi: 10.1002/ijc.26486.
    PubMed     Text format     Related articles    Abstract available



  13. GERSTENBLITH M , Rajaraman P, Khaykin E, Doody MM, et al
    Basal cell carcinoma and anthropometric factors in the U.S. radiologic technologists cohort study.
    Int J Cancer. 2011 Oct 11. doi: 10.1002/ijc.26480.
    PubMed     Text format     Related articles    Abstract available



    September 2011
  14. CARRETERO R , Wang E, Rodriguez AI, Reinboth J, et al
    Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon-mediated rejection genes.
    Int J Cancer. 2011 Sep 30. doi: 10.1002/ijc.26471.
    PubMed     Text format     Related articles    Abstract available



  15. PICCARD H , Berghmans N, Korpos E, Dillen C, et al
    Glycosaminoglycan mimicry by COAM reduces melanoma growth through chemokine induction and function.
    Int J Cancer. 2011 Sep 27. doi: 10.1002/ijc.26465.
    PubMed     Text format     Related articles    Abstract available



  16. TANESE K , Grimm EA, Ekmekcioglu S
    The role of melanoma tumor-derived nitric oxide in the tumor inflammatory microenvironment: Its impact on the chemokine expression profile, including suppression of CXCL10.
    Int J Cancer. 2011 Sep 22. doi: 10.1002/ijc.26451.
    PubMed     Text format     Related articles    Abstract available



  17. SEIBOLD P , Hein R, Schmezer P, Hall P, et al
    Polymorphisms in oxidative stress-related genes and postmenopausal breast cancer risk.
    Int J Cancer. 2011;129:1467-76.
    PubMed     Text format     Related articles    Abstract available



  18. GIAMMARIOLI AM , Gambardella L, Barbati C, Pietraforte D, et al
    Differential effects of the glycolysis inhibitor 2-deoxy-D-glucose on the activity of pro-apoptotic agents in metastatic melanoma cells, and induction of a cytoprotective autophagic response.
    Int J Cancer. 2011 Sep 12. doi: 10.1002/ijc.26420.
    PubMed     Text format     Related articles    Abstract available



  19. NIELSEN K , Masback A, Olsson H, Ingvar C, et al
    A prospective, population-based study of 40000 women regarding host factors, UV exposure and sunbed use in relation to risk and anatomic site of cutaneous melanoma.
    Int J Cancer. 2011 Sep 2. doi: 10.1002/ijc.26408.
    PubMed     Text format     Related articles    Abstract available



  20. SCHULTZ-THATER E , Piscuoglio S, Iezzi G, Le Magnen C, et al
    MAGE-A10 is a nuclear protein frequently expressed in high percentages of tumor cells in lung, skin and urothelial malignancies.
    Int J Cancer. 2011;129:1137-48.
    PubMed     Text format     Related articles    Abstract available



    August 2011
  21. BEGG CB
    A strategy for distinguishing optimal cancer subtypes.
    Int J Cancer. 2011;129:931-7.
    PubMed     Text format     Related articles    Abstract available



  22. ELLIOTT F , Suppa M, Chan M, Leake S, et al
    Relationship between sunbed use and melanoma risk in a large case-control study in the United Kingdom.
    Int J Cancer. 2011 Aug 5. doi: 10.1002/ijc.26347.
    PubMed     Text format     Related articles   



  23. METZIG M , Nickles D, Falschlehner C, Lehmann-Koch J, et al
    An RNAi screen identifies USP2 as a factor required for TNF-alpha-induced NF-kappaB signaling.
    Int J Cancer. 2011;129:607-18.
    PubMed     Text format     Related articles    Abstract available



    July 2011
  24. ALCAZAR O , Achberger S, Aldrich W, Hu Z, et al
    Epigenetic regulation by decitabine of melanoma differentiation in vitro and in vivo.
    Int J Cancer. 2011 Jul 27. doi: 10.1002/ijc.26320.
    PubMed     Text format     Related articles    Abstract available



  25. HATIBOGLU MA , Kong LY, Wei J, Wang Y, et al
    The tumor microenvironment expression of p-STAT3 influences the efficacy of cyclophosphamide with WP1066 in murine melanoma models.
    Int J Cancer. 2011 Jul 25. doi: 10.1002/ijc.26307.
    PubMed     Text format     Related articles    Abstract available



  26. CAHOON E , Rajaraman P, Alexander B, Doody M, et al
    Use of non-steroidal anti-inflammatory drugs and risk of basal cell carcinoma in the united states radiologic technologists study.
    Int J Cancer. 2011 Jul 21. doi: 10.1002/ijc.26286.
    PubMed     Text format     Related articles    Abstract available



  27. SPANGLER B , Kappelmann M, Schittek B, Meierjohann S, et al
    ETS-1/RhoC signaling regulates the transcription factor c-Jun in melanoma.
    Int J Cancer. 2011 Jul 5. doi: 10.1002/ijc.26277.
    PubMed     Text format     Related articles    Abstract available



    June 2011
  28. LIANG X , Pfeiffer RM, Wheeler W, Maeder D, et al
    Genetic variants in DNA repair genes and the risk of cutaneous malignant melanoma in melanoma-prone families with/without CDKN2A mutations.
    Int J Cancer. 2011 Jun 13. doi: 10.1002/ijc.26231.
    PubMed     Text format     Related articles    Abstract available



  29. TEKLE C , Nygren MK, Chen YW, Dybsjord I, et al
    B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes.
    Int J Cancer. 2011 Jun 13. doi: 10.1002/ijc.26238.
    PubMed     Text format     Related articles    Abstract available



  30. FERNANDEZ-RAMIRES R , Gomez G, Munoz-Repeto I, de Cecco L, et al
    Transcriptional characteristics of familial non-BRCA1/BRCA2 breast tumors.
    Int J Cancer. 2011;128:2635-44.
    PubMed     Text format     Related articles    Abstract available



    May 2011
  31. EKSTROM J , Bzhalava D, Svenback D, Forslund O, et al
    High throughput sequencing reveals diversity of human papillomaviruses in cutaneous lesions.
    Int J Cancer. 2011 May 31. doi: 10.1002/ijc.26204.
    PubMed     Text format     Related articles    Abstract available



  32. LUCAS S , van Baren N, de Smet C, Coulie PG, et al
    Demethylation of the FOXP3 gene in human melanoma cells precludes the use of this epigenetic mark for quantification of Tregs in unseparated melanoma samples.
    Int J Cancer. 2011 May 26. doi: 10.1002/ijc.26198.
    PubMed     Text format     Related articles    Abstract available



  33. YAMAUCHI C , Fujii S, Kimura T, Kuwata T, et al
    E-cadherin expression on human carcinoma cell affects trastuzumab-mediated antibody-dependent cellular cytotoxicity through killer cell lectin-like receptor G1 on natural killer cells.
    Int J Cancer. 2011;128:2125-37.
    PubMed     Text format     Related articles    Abstract available



    April 2011
  34. TROCME E , Mougiakakos D, Johansson CC, All-Eriksson C, et al
    Nuclear HER3 is associated with favourable overall survival in uveal melanoma.
    Int J Cancer. 2011 Apr 11. doi: 10.1002/ijc.26118.
    PubMed     Text format     Related articles    Abstract available



    March 2011
  35. HWANG CY , Chen YJ, Lin MW, Chen TJ, et al
    Cancer risk in allergic rhinitis, asthma, and atopic dermatitis: A nationwide cohort study in Taiwan.
    Int J Cancer. 2011 Mar 31. doi: 10.1002/ijc.26105.
    PubMed     Text format     Related articles    Abstract available



  36. YERAMIAN A , Sorolla A, Velasco A, Santacana M, et al
    Inhibition of activated receptor tyrosine kinases by Sunitinib induces growth arrest and sensitises melanoma cells to Bortezomib by blocking Akt pathway.
    Int J Cancer. 2011 Mar 28. doi: 10.1002/ijc.26096.
    PubMed     Text format     Related articles    Abstract available



  37. FECCHI K , Travaglione S, Spadaro F, Quattrini A, et al
    Human melanoma cells express FGFR/Src/Rho signaling that entails an adhesion-independent caveolin-1 membrane association.
    Int J Cancer. 2011 Mar 28. doi: 10.1002/ijc.26092.
    PubMed     Text format     Related articles    Abstract available



  38. LIU WM , Gravett AM, Dalgleish AG
    The antimalarial agent artesunate possesses anticancer properties that can be enhanced by combination strategies.
    Int J Cancer. 2011;128:1471-80.
    PubMed     Text format     Related articles    Abstract available



  39. MOREAU M , Mourah S, Dosquet C
    beta-Catenin and NF-kappaB cooperate to regulate the uPA/uPAR system in cancer cells.
    Int J Cancer. 2011;128:1280-92.
    PubMed     Text format     Related articles    Abstract available



  40. PANDEY V , Vijayakumar MV, Ajay AK, Malvi P, et al
    Diet induced obesity increases melanoma progression: Involvement of Cav-1 and FASN.
    Int J Cancer. 2011 Mar 8. doi: 10.1002/ijc.26048.
    PubMed     Text format     Related articles    Abstract available



  41. ORLOW I , Roy P, Reiner AS, Yoo S, et al
    Vitamin D receptor polymorphisms in patients with cutaneous melanoma.
    Int J Cancer. 2011 Mar 1. doi: 10.1002/ijc.26023.
    PubMed     Text format     Related articles    Abstract available



    February 2011
  42. BAADE P , Meng X, Youlden D, Aitken J, et al
    Time trends and latitudinal differences in melanoma thickness distribution in Australia, 1990-2006.
    Int J Cancer. 2011 Feb 22. doi: 10.1002/ijc.25996.
    PubMed     Text format     Related articles    Abstract available



  43. KASHUBA E , Yurchenko M, Yenamandra SP, Snopok B, et al
    Epstein-Barr virus-encoded EBNA-5 forms trimolecular protein complexes with MDM2 and p53 and inhibits the transactivating function of p53.
    Int J Cancer. 2011;128:817-25.
    PubMed     Text format     Related articles    Abstract available



  44. ZUEVA E , Rubio LI, Duconge F, Tavitian B, et al
    Metastasis-focused cell-based SELEX generates aptamers inhibiting cell migration and invasion.
    Int J Cancer. 2011;128:797-804.
    PubMed     Text format     Related articles    Abstract available



  45. CASTLE PE
    Do selective estrogen receptor modulators treat cervical precancer and cancer? Time to pool data from relevant trials.
    Int J Cancer. 2011;128:997-8.
    PubMed     Text format     Related articles   



  46. MOLHOEK KR , Erdag G, Rasamny J, Murphy C, et al
    VEGFR-2 expression in human melanoma: Revised assessment.
    Int J Cancer. 2011 Feb 3. doi: 10.1002/ijc.25963.
    PubMed     Text format     Related articles   



  47. HEYN H , Engelmann M, Schreek S, Ahrens P, et al
    MicroRNA miR-335 is crucial for the BRCA1 regulatory cascade in breast cancer development.
    Int J Cancer. 2011 Feb 3. doi: 10.1002/ijc.25962.
    PubMed     Text format     Related articles    Abstract available



  48. TENG Y , Liu M, Cowell JK
    Functional interrelationship between the WASF3 and KISS1 metastasis-associated genes in breast cancer cells.
    Int J Cancer. 2011 Feb 3. doi: 10.1002/ijc.25964.
    PubMed     Text format     Related articles   



  49. KLAWITTER J , Klawitter J, Gurshtein J, Corby K, et al
    Bezielle (BZL101)-induced oxidative stress damage followed by redistribution of metabolic fluxes in breast cancer cells: A combined proteomic and metabolomic study.
    Int J Cancer. 2011 Feb 3. doi: 10.1002/ijc.25965.
    PubMed     Text format     Related articles    Abstract available



  50. NADERI A , Liu J, Francis GD
    A feedback loop between BEX2 and ErbB2 mediated by c-Jun signaling in breast cancer.
    Int J Cancer. 2011 Feb 3. doi: 10.1002/ijc.25977.
    PubMed     Text format     Related articles    Abstract available



  51. FRIEDMAN GD , Udaltsova N, Habel LA
    Norepinephrine antagonists and cancer risk.
    Int J Cancer. 2011;128:737-8.
    PubMed     Text format     Related articles   



    December 2010
  52. CLAERHOUT S , Verschooten L, Van Kelst S, De Vos R, et al
    Concomitant inhibition of AKT and autophagy is required for efficient cisplatin-induced apoptosis of metastatic skin carcinoma.
    Int J Cancer. 2010;127:2790-803.
    PubMed     Text format     Related articles    Abstract available



  53. STENDAHL M , Nilsson S, Wigerup C, Jirstrom K, et al
    p27(Kip1) is a predictive factor for tamoxifen treatment response but not a prognostic marker in premenopausal breast cancer patients.
    Int J Cancer. 2010;127:2851-8.
    PubMed     Text format     Related articles    Abstract available



  54. WEIJERS EM , Koolwijk P, van Hinsbergh VW, van Nieuw Amerongen GP, et al
    Fibrin beta15-42 domain is cryptic in intact fibrinogen: comment on the study by A. Sahni et al.
    Int J Cancer. 2010;127:2981-2.
    PubMed     Text format     Related articles   



    November 2010
  55. COLEMAN JA , Correa I, Cooper L, Bohnenkamp HR, et al
    T cells reactive with HLA-A*0201 *peptides from the histone demethylase JARID1B are found in the circulation of breast cancer patients.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  56. SUZUKI R , Iwasaki M, Inoue M, Sasazuki S, et al
    Body weight at age 20 years, subsequent weight change and breast cancer risk defined by estrogen and progesterone receptor status-the Japan Public Health Center-based prospective study.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



    September 2010
  57. MURFF HJ , Shu XO, Li H, Yang G, et al
    Dietary polyunsaturated fatty acids and breast cancer risk in Chinese women: A prospective cohort study.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  58. MEGO M , De Giorgi U, Dawood S, Wang X, et al
    Characterization of metastatic breast cancer patients with non-detectable circulating tumor cells.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  59. WOOLCOTT CG , Cook LS, Courneya KS, Boyd NF, et al
    Associations of overall and abdominal adiposity with area and volumetric mammographic measures among postmenopausal women.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  60. MAGNUSSON C , Liu J, Ehrnstrom R, Manjer J, et al
    Cysteinyl leukotriene receptor expression pattern affects migration of breast cancer cells and survival of breast cancer patients.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  61. CHATTERJEE M , van Golen KL
    Farnesyl transferase inhibitor treatment of breast cancer cells leads to altered RhoA and RhoC GTPase activity and induces a dormant phenotype.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



    July 2010
  62. VAZQUEZ A , Kulkarni D, Grochola LF, Bond GL, et al
    A genetic variant in a PP2A regulatory subunit encoded by the PPP2R2B gene associates with altered breast cancer risk and recurrence.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  63. BAUERLE T , Komljenovic D, Merz M, Berger MR, et al
    Cilengitide inhibits progression of experimental breast cancer bone metastases as imaged non-invasively using VCT, MRI and DCE-MRI in a longitudinal in vivo study.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



    May 2010
  64. DOBBINS SE , Hosking FJ, Shete S, Armstrong G, et al
    Allergy and glioma risk: Test of association by genotype.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  65. EDVARDSEN K , Veierod MB, Brustad M, Braaten T, et al
    Vitamin D - effective solar UV radiation, dietary vitamin D and breast cancer risk.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  66. TAN JX , Wang XY, Li HY, Su XL, et al
    HYAL1 over-expression is correlated with the malignant behavior of human breast cancer.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  67. GANDINI S , Boniol M, Haukka J, Byrnes G, et al
    Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



    April 2010
  68. KANG DW , Park MH, Lee YJ, Kim HS, et al
    Autoregulation of phospholipase d activity is coupled to selective induction of phospholipase D1 expression to promote invasion of breast cancer cells.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  69. LIANG S , Pearl M, Liang S, Xiang L, et al
    Personal history of breast cancer as a significant risk factor for endometrial serous carcinoma in women </= 55 years OLD.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  70. NAIK MU , Pham NT, Beebe K, Dai W, et al
    Calcium-dependent inhibition of Polo-like kinase 3 activity by CIB1 in breast cancer cells.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  71. LEE E , Nichols P, Groshen S, Spicer D, et al
    GRP78 as potential predictor for breast cancer response to adjuvant taxane therapy.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: